These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 6135618

  • 1. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J.
    Eur J Pharmacol; 1983 May 20; 90(1):47-55. PubMed ID: 6135618
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade.
    Arnt J.
    Acta Pharmacol Toxicol (Copenh); 1982 Oct 20; 51(4):321-9. PubMed ID: 6129770
    [Abstract] [Full Text] [Related]

  • 3. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.
    Sumners C, De Vries JB, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1981 Apr 09; 70(4):541-50. PubMed ID: 6113149
    [Abstract] [Full Text] [Related]

  • 4. Desenkephalin-gamma-endorphin and neuroleptics counteract the DP-7-ATN-induced hypomotility after intra-accumbens treatment.
    Radhakishun FS, Horn AS, Van Ree JM.
    Eur J Pharmacol; 1988 Feb 16; 147(1):137-40. PubMed ID: 2897307
    [Abstract] [Full Text] [Related]

  • 5. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B, Domeney AM, Naylor RJ, Tyers MB.
    Br J Pharmacol; 1987 Dec 16; 92(4):881-94. PubMed ID: 2962686
    [Abstract] [Full Text] [Related]

  • 6. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
    Arnt J, Hyttel J.
    Eur J Pharmacol; 1984 Jul 13; 102(2):349-54. PubMed ID: 6148252
    [Abstract] [Full Text] [Related]

  • 7. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J.
    Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283
    [Abstract] [Full Text] [Related]

  • 8. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A, MacDonald C.
    Pharmacol Biochem Behav; 1986 Jun 11; 24(6):1639-43. PubMed ID: 2874567
    [Abstract] [Full Text] [Related]

  • 9. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV, Arnt J, Hyttel J, Svendsen O.
    Pol J Pharmacol Pharm; 1984 Jun 11; 36(2-3):249-64. PubMed ID: 6147830
    [Abstract] [Full Text] [Related]

  • 10. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
    Arnt J.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug 11; 330(2):97-104. PubMed ID: 2864641
    [Abstract] [Full Text] [Related]

  • 11. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist.
    Jolicoeur FB, Rivest R, St-Pierre S, Gagné MA, Dumais M.
    Neuropeptides; 1985 Apr 11; 6(2):143-56. PubMed ID: 2987745
    [Abstract] [Full Text] [Related]

  • 12. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R, Guerin JJ, Davis KL.
    Psychopharmacology (Berl); 1989 Apr 11; 98(3):386-91. PubMed ID: 2568659
    [Abstract] [Full Text] [Related]

  • 13. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K, Johansson AM, Magnusson T, Carlsson A.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov 11; 334(3):234-45. PubMed ID: 2880302
    [Abstract] [Full Text] [Related]

  • 14. Studies on the behavioural pharmacology of a cyclic analogue of dopamine following its injection into the brains of conscious rats.
    Elkhawad AO, Woodruff GN.
    Br J Pharmacol; 1975 May 11; 54(1):107-14. PubMed ID: 1139070
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov 11; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 16. Effects of GABA compounds injected into the subpallidal regions of rat brain on nucleus accumbens evoked hyperactivity.
    Patel S, Slater P.
    Behav Neurosci; 1988 Aug 11; 102(4):596-600. PubMed ID: 2844207
    [Abstract] [Full Text] [Related]

  • 17. Non-opiate beta-endorphin fragments and dopamine--III. gamma-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens.
    Van Ree JM, Caffé AR, Wolterink G.
    Neuropharmacology; 1982 Nov 11; 21(11):1111-7. PubMed ID: 6184640
    [Abstract] [Full Text] [Related]

  • 18. Effects of intrapallidal drugs on hyperactivity induced by nucleus accumbens dopamine receptor stimulation.
    Slater P, Longman DA, Dickinson SL.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec 11; 321(3):201-6. PubMed ID: 7155200
    [Abstract] [Full Text] [Related]

  • 19. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
    Van der Weide J, De Vries JB, Tepper PG, Krause DN, Dubocovich ML, Horn AS.
    Eur J Pharmacol; 1988 Mar 01; 147(2):249-58. PubMed ID: 3130270
    [Abstract] [Full Text] [Related]

  • 20. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
    Arnt J, Hyttel J, Larsen JJ.
    Acta Pharmacol Toxicol (Copenh); 1984 Nov 01; 55(5):363-72. PubMed ID: 6152104
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.